Opinion

Chow v. Archer-Daniels-Midland Company

Court
District Court, N.D. Illinois
Filed
Mar 12, 2025
Cited by
0 cases
Authority
More cited than 34.4%

finding that “resignations” can “suggest a higher level of wrongdoing approaching recklessness or even conscious malfeasance”

How later courts described this case

  • finding that “resignations” can “suggest a higher level of wrongdoing approaching recklessness or even conscious malfeasance”
  • finding scienter where a company violated GAAP and its own publicly stated accounting method
  • finding that officer resignations can “reinforce” allegations of scienter

Written by the judges who cited it.

The opinion

UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF ILLINOIS

EASTERN DIVISION

RAYMOND CHOW, individually and on

behalf of all others similarly situated,

No. 24 C 634

Plaintiff,

Judge Thomas M. Durkin

v.

ARCHER-DANIELS-MIDLAND COMPANY;

JUAN LUCIANO; VIKRAM LUTHAR; RAY

YOUNG; AND VINCIENT MACCIOCCHI,

Defendants.

MEMORANDUM OPINION AND ORDER

A class of shareholders of the Archer-Daniels-Midland Company (“ADM”)

allege that ADM and four of its officers made false statements in violation § 10(b) of

the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule

10b-5. They also claim violations of § 20(a) of the Exchange Act. Defendants have

each filed motions to dismiss, with ADM and its CEO, Juan Luciano, filing a joint

motion. All four motions are denied.

Legal Standard

A Rule 12(b)(6) motion challenges the “sufficiency of the complaint.” Gunn v.

Cont'l Cas. Co., 968 F.3d 802, 806 (7th Cir. 2020). A complaint must provide “a short

and plain statement of the claim showing that the pleader is entitled to relief,” Fed.

R. Civ. P. 8(a)(2), sufficient to provide defendant with “fair notice” of the claim and

the basis for it. Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007). This standard

“demands more than an unadorned, the-defendant-unlawfully-harmed-me

accusation.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). While “detailed factual

allegations” are not required, “labels and conclusions, and a formulaic recitation of

the elements of a cause of action will not do.” Twombly, 550 U.S. at 555. The

complaint must “contain sufficient factual matter, accepted as true, to ‘state a claim

to relief that is plausible on its face.’” Iqbal, 556 U.S. at 678 (quoting Twombly, 550

U.S. at 570). “Facial plausibility exists ‘when the plaintiff pleads factual content that

allows the court to draw the reasonable inference that the defendant is liable for the

misconduct alleged.’” Thomas v. Neenah Joint Sch. Dist., 74 F.4th 521, 523 (7th Cir.

2023) (quoting Iqbal, 556 U.S. at 678). In applying this standard, the Court accepts

all well-pleaded facts as true and draws all reasonable inferences in favor of the non-

moving party. See Hernandez v. Ill. Inst. of Tech., 63 F.4th 661, 666 (7th Cir. 2023).

In addition to the Rule 12(b)(6) standard, the “[h]eightened pleading

requirements” of Federal Rule of Civil Procedure 9(b) “apply to complaints alleging

fraud.” See Cornielsen v. Infinium Cap. Mgmt., LLC, 916 F.3d 589, 598 (7th Cir.

2019). Under Rule 9(b), a party alleging fraud or mistake “must state with

particularity the circumstances constituting fraud or mistake.” Fed. R. Civ. P. 9(b).

“Rule 9(b) requires a plaintiff to provide precision and some measure of

substantiation to each fraud allegation.” Menzies v. Seyfarth Shaw LLP, 943 F.3d

328, 338 (7th Cir. 2019) (internal quotation marks omitted). In other words, “a

plaintiff must plead the who, what, when, where, and how of the alleged fraud.” Id.

(internal quotation marks omitted).

Furthermore, the Private Securities Litigation Reform Act of 1995 (“PSLRA”)

imposes additional pleading requirements in securities fraud cases. See Cornielsen,

916 F.3d at 598-99. The PSLRA requires the complaint to “specify each statement

alleged to have been misleading, the reason or reasons why the statement is

misleading, and, if an allegation regarding the statement or omission is made on

information and belief, the complaint shall state with particularity all facts on which

that belief is formed.” 15 U.S.C. § 78u-4(b)(1). The complaint must also “state with

particularity facts giving rise to a strong inference that the defendant acted with the

required state of mind.” 15 U.S.C. § 78u-4(b)(2)(A).

Background

ADM is divided into three business “segments.” They are: (1) Ag Services and

Oilseeds, which focuses on buying, storing, reselling, and processing oilseeds1 and

soybeans; (2) Carbohydrate Solutions, which focuses on buying, storing, reselling, and

processing corn and wheat; and (3) Nutrition, which makes products animals and

people consume. Many of ADM’s Nutrition products are made from its soybeans,

seeds, corn, and wheat. ADM’s Nutrition segment purchases these ingredients from

the other two segments. ADM reported in SEC filings that it accounted for these

transactions at fair market value in accordance with Generally Accepted Accounting

Principles (“GAAP”). But beginning in 2018, ADM was actually accounting for these

transactions below fair market value. After the SEC initiated an investigation

1 “Oilseeds” are primarily used to make products like canola cooking oil.

regarding ADM’s intracompany transactions, it eventually admitted the erroneous

accounting in a corrected 10-K filing in March 2024.

By accounting for these transactions at below fair market value, ADM’s

Nutrition segment reported much higher profit than it was actually experiencing.

This allegedly caused ADM’s stock price to increase from $35 to $90 between 2020

and 2022. When ADM filed its corrected report with the SEC, its stock price fell to

$50.

Two years after ADM began improperly accounting for the Nutrition segment’s

transactions, ADM’s board altered the compensation of its officers so that it was tied

to the growth of the Nutrition segment. In this way, ADM’s officers, including the

four Individual Defendants in this case, directly benefited from the inaccurate

accounting of the Nutrition segment’s profits.2 The Individual Defendants also took

advantage of ADM’s inflated stock price by selling millions of dollars’ worth of ADM

stock during this time period. By contrast, the Individual Defendants did not sell any

ADM stock before the Nutrition segment began to show inflated profits.

Plaintiffs allege that Defendants’ reports to the SEC that the Nutrition

segment made intracompany purchases at fair market value was a false statement.

Plaintiffs also allege that the violations of GAAP with regard to the Nutrition

2 The “Individual Defendants” are the following four people: (1) Juan Luciano is

ADM’s Chief Executive Officer, President, and Chairman of the Board; (2) Vikram

Luthar was ADM’s Chief Financial Officer from 2022 until 2024, and had worked for

ADM in various positions since 2004; (3) Ray Young was ADM’s Chief Financial

Officer from 2010 until 2022; and (4) Vincient Macciocchi was ADM’s former

President of Nutrition from 2015 until 2023, and also served as Chief Sales and

Marketing Officer from 2020 until 2023.

segment accounting resulted in Defendants making false statements about the

Nutrition segment’s profits and growth. Additionally, Plaintiffs allege that

Defendants falsely stated that ADM’s “internal controls” were effective when they

knew that the Nutrition segment accounting was incorrect.

Analysis

Plaintiffs claim that these false statements violated § 10(b) of the Securities

Exchange Act and SEC Rule 10b-5. The elements of a claim under § 10(b) and Rule

10b-5 are: “(1) a material misrepresentation or omission by the defendant; (2)

scienter; (3) a connection between the misrepresentation or omission and the

purchase or sale of a security; (4) reliance upon the misrepresentation or omission;

(5) economic loss; and (6) loss causation.” Stoneridge Inv. Partners, LLC v. Sci.-

Atlanta, 552 U.S. 148, 157 (2008).

I. Falsity

Defendants argue that Plaintiffs have failed to plausibly allege that

Defendants’ statements about the Nutrition segment’s profits and growth and ADM’s

internal controls were false. But Defendants do not argue that ADM’s misstatements

in its SEC reports regarding the Nutrition segment’s accounting of intracompany

transactions were accurate. In other words, Defendants implicitly concede that the

statements about the intracompany transactions being accounted for in accordance

with GAAP were plausibly false. This is likely because ADM admitted as much in the

corrected 10-K filing of March 2024.

Plaintiffs allege that this implicit concession is sufficient to plausibly allege

with particularity a false statement for purposes of their § 10(b) claim, such that it is

unnecessary for the Court to reach Defendants’ arguments that Plaintiffs have failed

to plausibly allege the falsity of the other categories of statements. Defendants

disagree and argue that Plaintiffs are required to plausibly allege the falsity of every

statement on which they base a claim for a § 10(b) violation.

But whether the statements regarding the Nutrition segment’s profits and the

statements regarding ADM’s internal controls are plausibly false is dependent upon

the falsity of the statements regarding the Nutrition segment’s accounting. ADM

conceded in its corrected 10-K that it misstated its accounting practices in its reports

to the SEC. This concession by ADM is sufficient to plausibly establish with

particularity the falsity of the statements regarding the Nutrition segment’s

accounting. If Defendants plausibly knew the statements about the accounting were

false, then Defendants plausibly also knew that their statements about the Nutrition

segment’s profits and ADM’s internal controls were also false. This is because it

cannot be true that a company conducting fraudulent accounting (1) can be said to

have sufficient internal controls, and (2) can be said to have legitimate reported

profits. Defendants’ arguments about “partial truth” and “puffery” are irrelevant if

they plausibly knew the accounting was incorrect. Thus, if Plaintiffs have plausibly

alleged “scienter” they have plausibly alleged the falsity of the statements regarding

the Nutrition segment’s profits and ADM’s internal controls.

II. Scienter

The state of mind necessary to state a claim under § 10(b) is described as

“scienter,” which “means an intent to deceive, demonstrated by knowledge of the

statement’s falsity or reckless disregard of a substantial risk that the statement is

false.” Cornielsen, 916 F.3d at 601 (7th Cir. 2019). Like falsity, “scienter,” must be

alleged with “particularity” by identifying “facts giving rise to a strong inference that

the defendant acted with the required state of mind.” 15 U.S.C. § 78u-4(b)(2)(A). The

allegation of scienter “must be more than merely plausible or reasonable—it must be

cogent and at least as compelling as any opposing inference of nonfraudulent intent.”

Tellabs, Inc. v. Makor Issues & Rts., Ltd., 551 U.S. 308, 314 (2007). To satisfy the

PSLRA’s specificity requirements in multi-defendant cases, a plaintiff “must create a

strong inference of scienter with respect to each individual defendant.” Pugh v.

Tribune Co., 521 F.3d 686, 693 (7th Cir. 2008); see also Cornielsen, 916 F.3d at 602.

Corporate scienter cannot be established in the absence of any individual corporate

official’s scienter. See Makor Issues & Rights, Ltd. v. Tellabs Inc., 513 F.3d 702, 708

(7th Cir. 2008).

Here, although Plaintiffs do not allege direct evidence that Defendants knew

the statements to the SEC about the accounting were false, the allegations of

circumstantial evidence of their knowledge are strong. The primary evidence of

scienter centers on the Individual Defendants’ pecuniary interests. Two years after

the false accounting practice was implemented, Defendants changed their

compensation structure to benefit from it. Specifically, under the new structure,

Defendants’ compensation was directly tied to the profits of the Nutrition segment

specifically, rather than that of ADM as a whole. This chain of events plausibly

suggests a motive to at least maintain the fraudulent practice. Further, Defendants

then took advantage of the Nutrition segment’s allegedly fraudulent profit reports by

selling stock during the class period.

Additionally, the Individual Defendants, as ADM’s highest-ranking officers,

had direct responsibility for entering into, monitoring, and publicly reporting on the

Nutrition segment’s profits. Indeed, the Individual Defendants made public

statements describing their knowledge and responsibility for the Nutrition segment’s

profits. See R. 67 ¶¶ 255-258, 268-272. And Courts have frequently held that

“[o]fficers of a company can be assumed to know of facts ‘critical to a business’s core

operations or to an important transaction that would affect a company’s

performance.’” In re Sears, Roebuck & Co. Sec. Litig., 291 F. Supp. 2d 722, 727 (N.D.

Ill. 2003); see also Azar v. Grubhub, Inc., 2021 WL 4077327, at *6 (N.D. Ill. Sept. 7,

2021) (same). There are many allegations in the complaint showing that ADM and

its officers considered the Nutrition segment to be at the “core” of ADM’s growth plan.

See, e.g., R. 67 ¶¶ 40-41, ¶ 56-57.

Furthermore, the accounting fraud did not involve complex accounting

standards or require the exercise of judgment. See id. ¶ 276. Rather, ADM had a long-

standing policy of booking inter-segment sales at market rates, and GAAP required

only that ADM follow that publicly-disclosed policy. See id. ¶¶ 275-277. ADM followed

this GAAP policy for sales between its other two business segments but violated the

same GAAP policy for transfers to the Nutrition segment. See id. ¶¶ 277-279. Further,

the Individual Defendants made many public statements demonstrating their

knowledge about the Nutrition segment and its profits. See id. ¶¶ 124-57, 281-293.

In this context, the apparent simplicity of the accounting fraud provides further

support for a strong inference of knowing or deliberate disregard. Other court have

reached similar findings in similar circumstances. See In re MicroStrategy, Inc. Sec.

Litig., 115 F. Supp. 2d 620, 637 (E.D. Va. 2000) (finding scienter where a company

violated GAAP and its own publicly stated accounting method); In re Medicis Pharm.

Corp. Sec. Litig., 2010 WL 3154863, at *6-*7 (D. Ariz. Aug. 9, 2010) (same).

To top it all off, several of the Individual Defendants left their positions after

the false reports were disclosed, and ADM is the subject of government investigations

based on the false reports to the SEC. See Heavy & Gen. Laborers’ Loc. 472 & 172

Pension & Annuity Funds v. Fifth Third Bancorp, 2022 WL 1642221, at *22 (N.D. Ill.

May 24, 2022) (“Government investigations can help to reinforce allegations of

scienter[.]”); In re Akorn, Inc. Sec. Litig., 240 F. Supp. 3d 802, 820 (N.D. Ill. 2017)

(finding that officer resignations can “reinforce” allegations of scienter); In re OSG

Sec. Litig., 12 F. Supp. 3d 622, 632-633 (S.D.N.Y. 2014) (finding that “resignations”

can “suggest a higher level of wrongdoing approaching recklessness or even conscious

malfeasance”); San Antonio Fire & Police Pension Fund v. Dentsply Sirona Inc., 2024

WL 1898512, at *11 (S.D.N.Y. May 1, 2024) (same). Both these facts cement the

strong inference that can be drawn from the allegations reviewed above that the

Individual Defendants were aware that ADM had misstated its accounting process.

Defendants pick apart Plaintiffs’ allegations and point to cases finding that

each type of allegation Plaintiffs include in their complaint is insufficient in isolation

to establish a strong inference of scienter. But this case is different. Here, Plaintiffs

have made strong allegations of motive, public statements, the core nature of the

Nutrition segment, and the straightforward nature of the fraud. These allegations

combined with the suspicious departures and government investigations create a

strong inference of scienter. Defendants cite no case with allegations this robust

where a court granted a motion to dismiss.

Defendants’ argument regarding the allegation of motive is a case in point.

Defendants argue that “courts consistently decline to infer scienter from . . . a generic

corporate incentive.” R. 80 at 18. But there is nothing generic about the incentives at

issue here. A “generic” incentive would be the commonplace incentive structure in

which officer compensation is linked to the profits of a company as a whole. Here, the

Individual Defendants’ compensation was linked to a specific segment of the

company. The traditional compensation structure was changed in the wake of ADM

beginning the fraudulent accounting practices. Defendants’ compensation structure

enabled them to directly benefit from the fraudulent accounting practices.

Defendants then allegedly took advantage of these circumstances further by selling

ADM stock after it doubled in value when they had not sold stock previously.

Defendants argue, both in their briefs and at oral argument, that the two years

between the beginning of the accounting fraud and the compensation structure

change cuts against the compensation structure change being evidence of scienter.

See R. 92 at 9. Certainly, if the accounting fraud and compensation structure change

had begun simultaneously it would have been a very strong indication that the two

actions were connected. However, the temporal separation does not necessarily

undercut the strength of the allegations that the compensation structure indicates

knowledge of the fraud. This is because the decision to tie the Individual Defendants’

compensation to the Nutrition segment’s performance suggests that the Individual

Defendants would have closely examined the Nutrition segment’s financial records.

ADM’s board ultimately made the decision to change the compensation structure, but

the Individual Defendants were all either board members or high-ranking officers

who had responsibility for advising the board on such an important decision. It is

highly unlikely that the Individual Defendants did not closely review the planned

change in compensation structure and examine the underling relevant financial

information. And Plaintiffs allege that a close examination of the accounting would

have revealed the fraud. See R. 67 ¶¶ 275-78. Instead, the Individual Defendants

allegedly decided to perpetuate and take advantage of the fraud. So, while the two-

year separation might indicate that the change in compensation structure does not

necessarily indicate knowledge of the fraud, it just as easily can be understood the

other way. And in light of the allegation that the accounting fraud was not

complicated, the Court finds that the change in compensation structure makes it

more likely that the Individual Defendants, and by extension ADM itself, were aware

of the fraud.

As in all cases, there are potential alternative explanations for these facts.

Defendants urge the Court to find that the alternative explanations outweigh the

inferences Plaintiffs ask the Court to draw. But this series of events is highly

suspicious and can hardly be described as “generic.” Common sense says that the

change in incentive structure is as close as circumstantial evidence can be to direct

evidence that Defendants knew about the accounting misstatements.

Lastly, Defendants’ only argument that the § 20(a) claims should be dismissed

is because they are dependent on the same factual allegations at the § 10(b) claims.

Having denied the motions to dismiss the § 10(b) claims, the motions to dismiss the

§ 20(a) claims are denied as well.

Conclusion

Therefore, Defendants’ motions to dismiss [79] [81] [83] [87] are denied.

ENTERED:

Arnie MY Suchor.

Honorable Thomas M. Durkin

United States District Judge

Dated: March 12, 2025

12

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.